SCHEMBL21486405

SCHEMBL21486405

Cc1ccc(O)c(C(=O)c2ccccc2F)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A1 P68400 1/20 0.53
RAB9A P51151 4/20 0.50
LMNA P02545 4/20 0.50
KDM4E B2RXH2 3/20 0.50
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
GSTA1 P08263 2/20 0.47
MAPT P10636 6/20 0.47
HPGD P15428 3/20 0.47
HTT P42858 3/20 0.47
TSHR P16473 4/20 0.47
HSD17B10 Q99714 3/20 0.47
NPC1 O15118 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
CES2 O00748 1/20 0.46
CES1 P23141 1/20 0.46
ALDH1A1 P00352 3/20 0.45
GMNN O75496 1/20 0.44
TTR P02766 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30070831 1.00 CSNK2A1 (0.53) CSNK2A1RAB9ALMNAKDM4EMEN1
SCHEMBL11755563 0.88 CES2 (0.50) RAB9ALMNAKDM4EMEN1KMT2A
SCHEMBL5962983 0.86 GSTA1 (0.62) CSNK2A1RAB9ALMNAKDM4EMEN1
SCHEMBL11500852 0.84 CSNK2A1 (0.72) CSNK2A1RAB9ALMNAKDM4EMEN1
SCHEMBL2704094 0.83 MAPT (0.54) RAB9ALMNAKDM4EMEN1KMT2A
SCHEMBL11756492 0.83 CSNK2A1 (0.56) CSNK2A1RAB9ALMNAKDM4EMEN1
SCHEMBL1960435 0.81 CSNK2A1 (0.70) CSNK2A1RAB9ALMNAKDM4EMEN1
SCHEMBL11646628 0.80 KCNMA1 (0.60) RAB9ALMNAMEN1KMT2AGSTA1
SCHEMBL144475 0.80 KMT2A (0.70) CSNK2A1RAB9ALMNAKDM4EMEN1
SCHEMBL9390040 0.80 CES2 (0.58) RAB9ALMNAKDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210155591-A1 2-(2,2-DIARYLETHYL)-CYCLIC AMINE DERIVATIVE OR SALT, SYNTHESIS THEREOF, AND APPLICATION AND COMPOSITION THEREOF DALIAN INSTITUTE OF CHEMICAL PHYSICS, CHINESE ACADEMY OF SCIENCES (CN) 2021-05-27 US disclosed
WO-2019196898-A1 2-(2,2-DIARYLETHYL)-CYCLIC AMINE DERIVATIVE OR SALT, SYNTHESIS THEREOF, AND APPLICATION AND COMPOSITION THEREOF 中国科学院大连化学物理研究所 2019-10-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210155591-A1 2-(2,2-DIARYLETHYL)-CYCLIC AMINE DERIVATIVE OR SALT, SYNTHESIS THEREOF, AND APPLICATION AND COMPOSITION THEREOF CHRNB2, ADRB2, CHRNB1 CSNK2A1 776/4885RAB9A 609/4885LMNA 4554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.